Phase III clinical trials primarily involve:

• A. Phase III: determine whether the drug is effective, how it compares with other proven treatments, and how to use it in the safest way
• B. Phase III: tests safety in a small group
• C. Phase III: compare price with alternatives
• D. Phase III: test the drug in animals

Answer: (A)

Phase III trials are large-scale studies designed to determine whether a new drug actually works in practice and how it compares to existing proven treatments, while also establishing the best and safest way to use it. This phase tests efficacy in a broader, more diverse patient population and gathers data on safety, dosing, and practical use that inform labeling and clinical guidelines. The aim is to confirm benefits observed in earlier studies and to understand how the drug performs against standard care or placebo in real-world settings.

The other descriptions fit earlier stages or different activities: testing safety in a small group aligns with early-phase work focused on dosing and tolerability; price comparisons aren’t a trial objective; and animal testing occurs before human trials.